| Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
| 1 | ? | 11q12.2-11q12.3 |  | Spinocerebellar ataxia 20 - SCA20 (13.18)
|
|
| 2 | ? | 18q21 | | Amyotrophic lateral sclerosis - ALS3 (12.56)
|
|
| 3 | ? | 20p13 | | Amyotrophic lateral sclerosis - ALS7 (12.60)
|
|
| 4 | ? | 14q12-q22 | | Arrhythmogenic right ventricular cardiomyopathy 3 - ARVC3 (10.117)
| | Arrhythmogenic right ventricular dysplasia-3 - ARVD3 (10.117)
|
|
| 5 | ? | 2q32.1-q32.3 | | Arrhythmogenic right ventricular cardiomyopathy 4 - ARVC4 (10.118)
| | Arrhythmogenic right ventricular dysplasia, familial, 4 - ARVD4 (10.118)
|
|
| 6 | ? | 10q22-q24 | | Atrial fibrillation, 1 - ATFB1 (10.158)
|
|
| 7 | ? | 10q22-q24 | | Atrial fibrillation, 2 - ATFB2 (10.159)
|
|
| 8 | ? | 4q25 | | atrial fibrillation, familial, 5 - ATFB5 (10.162)
|
|
| 9 | ? | 16q22 | | atrial fibillation, familial, 8 - ATFB8 (10.165)
|
|
| 10 | ? | 9q13 | | Cardiomyopathy, familial dilated, 1 - CMD1B (10.40)
|
|
| 11 | ? | 6q23 | | Dilated cardiomyopathy, 1F - CMD1F
|
|
| 12 | ? | 2q14-q22 | | Cardiomyopathy, dilated, 1H - CMD1H (10.45)
|
|
| 13 | ? | 6q12-q16 | | Cardiomyopathy, dilated, 1K - CMD1K (10.48)
|
|
| 14 | ? | 7q22.3-q31.1 | | Cardiomyopathy, dilated, 1Q - CMD1Q (10.54)
|
|
| 15 | ? | 7p12.1-q21 | | Hypertrophic cardiomyopathy, 21 - CMH28 (10.23)
|
|
| 16 | ? | 8q21.3 | | Charcot-Marie-Tooth neuropathy Type 2H - CMT2H (14.54)
|
|
| 17 | ? | 10q24.1-q25.1 | | charcot-marie-tooth neuropathy, dominant intermediate A - CMTDIA
|
|
| 18 | ? | Xp22.2 | | charcot-marie-tooth disease, x-linked recessive, 2 - CMTX2 (14.38)
|
|
| 19 | ? | 11q13 | | spinal muscular atrophy, distal, autosomal recessive, 3 - DSMA3 (12.7)
|
|
| 20 | ? | 2q31.3-q32.1 | | Arthrogryposis, distal, type 10 - DA10 (17.20)
|
|
| 21 | ? | 7q34-q36 | | Neuronopathy, distal hereditary motor, type I - HMN1 (12.23)
|
|
| 22 | ? | 1q42 | | episodic ataxia type-3 - EA3 (13.49)
|
|
| 23 | ? | 19q13 | | episodic ataxia type-7 - EA7 (13.52)
|
|
| 24 | ? | 9p23-p11 | | friedreich ataxia 2 - FRDA2 (13.58)
|
|
| 25 | ? | 4q34.3-q35.2 | | Hereditary motor and sensory neuropathy V - HMSN5 (12.38)
|
|
| 26 | ? | 3p24-p22 | | hereditary sensory and autonomic neuropathy type ib with cough and gastroesophag - HSAN1B (14.103)
|
|
| 27 | ? | 4q21 | | Muscular dystrophy, limb-girdle, type 1G - LGMD1G
|
|
| 28 | ? | 3p23-p25 | | Limb-girdle, muscular dystrophy, type 1h - LGMD1H (1.21)
|
|
| 29 | ? | 11q15 | | Left ventricular noncompaction 2 - LVNC2 (10.105)
|
|
| 30 | ? | 1Q42 | |
| 31 | ? | 1q42 | | Congenital muscular dystrophy - MDC1B (2.45)
| | Congenital muscular dystrophy with merosin deficiency - MDC1B (2.45)
|
|
| 32 | ? | 19p13 | | Muscular dystrophy, autosomal dominant, with rimmed vacuoles - MDRV
|
|
| 33 | ? | 11q13.2q14.1 | |
| 34 | ? | 10q22 | | arrhythmogenic right ventricular dysplasia, familial, 7 - ARVD7
|
|
| 35 | ? | 17q11.2-q24 | | Malignant hyperthermia susceptibility 2 - MHS2 (8.2)
|
|
| 36 | ? | 7q21-q22 | | Malignant hyperthermia susceptibility 3 - MHS3 (8.3)
|
|
| 37 | ? | 3q13.1 | | Malignant hyperthermia susceptibility 4 - MHS4 (8.4)
|
|
| 38 | ? | 5p | | Malignant hyperthermia susceptibility 6 - MHS6 (8.6)
|
|
| 39 | ? | 8q22.3 | | Miyoshi muscular dystrophy 2 - MMD2 (4.2)
|
|
| 40 | ? | 10 | | Restrictive cardiomyopathy, 2 - RCM2 (10.97)
|
|
| 41 | ? | 1q41 | | Rippling muscle disease, dominant - RMD1 (6.5)
|
|
| 42 | ? | 1p21-q23 | | Spinocerebellar ataxia 21 - SCA22 (13.20)
|
|
| 43 | ? | 3p26 | | Cerebellar ataxia, congenital, nonprogressive, autosomal dominant - SCA29 (13.26)
|
|
| 44 | ? | 4q34.3-q35.1 | | Spinocerebellar ataxia 30 - SCA30 (13.27)
|
|
| 45 | ? | 7q32-q33 | | Spinocerebellar ataxia 32 - SCA32 (13.29)
|
|
| 46 | ? | 1p32 | | Spinocerebellar ataxia 37 - SCA37 (13.33)
|
|
| 47 | ? | 16q22.1 | | Spinocerebellar ataxia 4 - SCA4 (13.4)
|
|
| 48 | ? | 6p23-p21 | | Spinocerebellar ataxia, autosomal recessive 3 - SCAR3 (13.63)
|
|
| 49 | ? | 20q11-q13 | | Spinocerebellar ataxia, autosomal recessive 6 - SCAR6 (13.66)
|
|
| 50 | ? | 11p15 | |
| 51 | ? | 3q27-q28 | | Spastic paraplegia 14 - SPG14 (15.28)
|
|
| 52 | ? | Xq11.2-q23 | | Spastic paraplegia 16 - SPG16 (15.89)
|
|
| 53 | ? | 9q33-q34 | | Spastic paraplegia 19 - SPG19 (15.10)
|
|
| 54 | ? | 1q24-q32 | | Spastic paraplegia 23 - SPG23 (15.33)
|
|
| 55 | ? | 13q14 | | Spastic paraplegia 24 - SPG24 (15.34)
|
|
| 56 | ? | 6q23.3-q24.1 | | Spastic paraplegia 25 - SPG25 (15.35)
|
|
| 57 | ? | 10q22.1-q24.1 | | Spastic paraplegia 27 - SPG27 (15.37)
|
|
| 58 | ? | 1p31-p21 | | Spastic paraplegia 29 - SPG29 (15.11)
|
|
| 59 | ? | 14q12-q21 | | spastic paraplegia 32, autosomal recessive - SPG32 (15.40)
|
|
| 60 | ? | Xq24-q25 | | Spastic paraplegia 34, X-linked - SPG34 (15.90)
|
|
| 61 | ? | 12q23-q24 | | Spastic paraplegia 36, autosomal dominant - SPG36 (15.15)
|
|
| 62 | ? | 8p21.1-q13.3 | | Spastic paraplegia 37, autosomal dominant - SPG37 (15.16)
|
|
| 63 | ? | 4p16-p15 | | Spastic paraplegia 38, autosomal dominant - SPG38 (15.17)
|
|
| 64 | ? | 11p14.1-p11.2 | | Spastic paraplegia 41, autosomal dominant - SPG41 (15.18)
|
|
| 65 | ? | Xp22.3 | | episodic muscle weakness, x-linked - EMWX (5.36)
|
|